6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Psychophysiology of Addiction
The psychophysiology of addiction examines the physiological changes that occur in the body and brain due to substance use, and how these changes influence behavior and mental health. Addiction impacts neurotransmitter systems, particularly those involving dopamine, serotonin, and GABA, which are responsible for regulating mood, reward, and stress responses. The brain’s reward system, when repeatedly activated by substance use, becomes dysregulated, leading to compulsive drug-seeking behavior. In addition to altering brain chemistry, addiction can lead to physical changes in the body, including disrupted sleep patterns, altered heart rate, and increased stress responses. Understanding the psychophysiological underpinnings of addiction provides critical insights for developing effective, multi-faceted treatments that address both the mind and body’s response to substance use.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States